首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1422819

2024-2032 年聚乙二醇化蛋白質市場報告（按產品、蛋白質類型、應用、最終用戶和地區）

PEGylated Proteins Market Report by Product, Protein Type, Application, End User, and Region 2024-2032

出版日期: 2024年01月30日 | 出版商:

IMARC | 英文 144 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2023年全球聚乙二醇化蛋白市場規模達13億美元。展望未來， IMARC Group預計到2032年市場規模將達到28億美元，2024-2032年複合年成長率（CAGR）為8.87%。慢性病盛行率的增加、癌症治療中產品的廣泛使用以及聚乙二醇化蛋白產品批准數量的不斷增加是推動市場發展的一些關鍵因素。

聚乙二醇化蛋白質是透過與聚乙二醇 (PEG) 共價結合進行修飾的生物分子。它涉及聚乙二醇化技術，透過改變生物分子的物理和化學特性（例如其構象、靜電結合和疏水性）來改善藥物的藥物動力學行為。聚乙二醇化蛋白廣泛用於治療應用，例如疫苗、荷爾蒙替代療法、遺傳性疾病、貧血和凝血障礙。它也用於治療多種疾病的藥物，包括腎臟病、多發性硬化症、血友病和癌症。聚乙二醇化蛋白質有助於延長半衰期，增加穩定性、溶解度和蛋白水解保護，減少腎臟排泄、免疫原性和毒性，並增強藥物傳遞的功效。除此之外，聚乙二醇化蛋白質無毒性、水溶性、親水性、非抗原性和非免疫原性。

聚乙二醇化蛋白質市場趨勢：

全球腎臟疾病、自體免疫疾病、遺傳性疾病、肝炎和類風濕性關節炎等慢性病盛行率的上升是推動市場成長的關鍵因素之一。聚乙二醇化蛋白廣泛用於治療發炎、向細胞傳遞校正基因、預防血栓、傳遞生長激素、預防慢性腎臟病的進展。與此一致的是，在癌症治療中廣泛使用產品將化療藥物直接輸送到癌細胞並減少對健康細胞的副作用，有利於市場成長。除此之外，聚乙二醇化技術的各種改進，例如開發可以生產更小和更複雜分子的新聚乙二醇化方法，正在為市場成長提供動力。此外，廣泛採用聚乙二醇化來提高集落刺激因子 (CSF) 的穩定性和半衰期，使它們作為治療劑更有效，這也是另一種生長誘導因子。此外，與非蛋白質藥物相比，蛋白質藥物的採用率不斷上升，其中聚乙二醇化增加了蛋白質的循環和半衰期，提高了其效率，正在推動市場成長。其他因素，包括聚乙二醇化蛋白產品批准數量的增加、生物技術和分子生物學工程領域的發展、聚乙二醇分子在生物製藥中的整合及其相關優勢、老年人口的增加以及各種政府舉措的實施製藥業的監管標準預計將推動市場進一步成長。

本報告回答的關鍵問題

全球聚乙二醇化蛋白市場有多大？
2024-2032年全球聚乙二醇化蛋白市場的預期成長率是多少？
推動全球聚乙二醇化蛋白質市場的關鍵因素是什麼？
COVID-19 對全球聚乙二醇化蛋白市場有何影響？
基於該產品的全球聚乙二醇化蛋白市場的詳細情形如何？
根據蛋白質類型，全球聚乙二醇化蛋白質市場的詳細情形如何？
根據應用，全球聚乙二醇化蛋白市場的詳細情形如何？
根據最終用戶，全球聚乙二醇化蛋白質市場的詳細情形如何？
全球聚乙二醇化蛋白市場的關鍵區域有哪些？
誰是全球聚乙二醇化蛋白質市場的主要參與者/公司？

北美洲
- 美國
  - 市場走向
  - 市場預測
- 加拿大
  - 市場走向
  - 市場預測
亞太
- 中國
  - 市場走向
  - 市場預測
- 日本
  - 市場走向
  - 市場預測
- 印度
  - 市場走向
  - 市場預測
- 韓國
  - 市場走向
  - 市場預測
- 澳洲
  - 市場走向
  - 市場預測
- 印尼
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
歐洲
- 德國
  - 市場走向
  - 市場預測
- 法國
  - 市場走向
  - 市場預測
- 英國
  - 市場走向
  - 市場預測
- 義大利
  - 市場走向
  - 市場預測
- 西班牙
  - 市場走向
  - 市場預測
- 俄羅斯
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
拉丁美洲
- 巴西
  - 市場走向
  - 市場預測
- 墨西哥
  - 市場走向
  - 市場預測
- 其他
  - 市場走向
  - 市場預測
中東和非洲
- 市場走向
- 市場細分：按國家/地區
- 市場預測

第 11 章：促進因素、限制與機會

概述
促進要素
限制
機會

第 12 章：價值鏈分析

第 13 章：波特五力分析

概述
買家的議價能力
供應商的議價能力
競爭程度
新進入者的威脅
替代品的威脅

第 14 章：價格分析

第15章：競爭格局

市場結構
關鍵參與者
關鍵參與者簡介
- Abcam plc
- Biomatrik Inc.
- Creative PEGWorks
- Iris Biotech GmbH
- JenKem Technology USA Inc.
- Laysan Bio Inc.
- NOF America Corporation (NOF Corporation)
- Profacgen
- Thermo Fisher Scientific Inc.

簡介目錄圖表

Product Code: SR112024A7070

Abstract

The global PEGylated proteins market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.8 Billion by 2032, exhibiting a growth rate (CAGR) of 8.87% during 2024-2032. The increasing prevalence of chronic diseases, the widespread product utilization in cancer treatment, and the escalating number of product approvals for PEGylated proteins represent some of the key factors driving the market.

PEGylated proteins are biomolecules that have been modified by covalent conjugation with polyethylene glycol (PEG). It involves the PEGylation technique that improves the pharmacokinetic behavior of the medicine by altering the biological molecule's physical and chemical characteristics, such as its conformation, electrostatic binding, and hydrophobicity. PEGylated proteins are widely used in therapeutic applications, such as vaccines, hormone replacement therapy, genetic disorders, anemia, and blood clotting disorder. It is also used in various drugs for diseases, including kidney disease, multiple sclerosis, hemophilia, and cancers. PEGylated proteins help in the extension of half-life, increasing stability, solubility, and proteolytic protection, reducing renal excretion, immunogenicity, and toxicity, and enhancing the efficacy of drug delivery. Besides this, PEGylated proteins are non-toxic, water-soluble, hydrophilic, non-antigenic, and non-immunogenic.

PEGylated Proteins Market Trends:

The rising prevalence of chronic diseases, such as kidney ailments, autoimmune diseases, genetic disorders, hepatitis, and rheumatoid arthritis across the globe is one of the key factors driving the market growth. PEGylated proteins are widely used to treat inflammation, deliver corrective genes to cells, prevent blood clots, deliver growth hormones, and prevent the progression of chronic kidney disease. In line with this, the widespread product utilization in cancer treatment to deliver chemotherapy drugs directly to cancer cells and reduce the side effects on healthy cells is favoring the market growth. Apart from this, various improvements in the PEGylation technology, such as the development of new PEGylation methods that can produce smaller and more complex molecules, are providing an impetus to the market growth. Additionally, the widespread adoption of PEGylation to improve the stability and half-life of colony-stimulating factors (CSFs), making them more effective as therapeutic agents, is acting as another growth-inducing factor. Furthermore, the rising adoption of protein-based drugs over non-protein-based drugs wherein PEGylation increases the circulation and half-life of the proteins, improving its efficiency, is propelling the market growth. Other factors, including the increasing number of product approvals for PEGylated proteins, development in the field of biotechnology and molecular biology engineering, the integration of PEG molecules in biopharmaceuticals and the associated advantages, rising geriatric population, and the implementation of various government initiatives to increase regulatory standards in the pharmaceutical industry, are anticipated drive the market further toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global PEGylated proteins market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on product, protein type, application, and end user.

Product Insights:

Consumables

PEGylation Reagents

PEGylation Kits

Services

A detailed breakup and analysis of the PEGylated proteins market based on the product has also been provided in the report. This includes consumables (PEgylation reagents and PEgylation kits) and services. According to the report, consumables accounted for the largest market share.

Protein Type Insights:

Colony Stimulating Factors

Interferons

Erythropoietin

mAbs

Recombinant Factor VII

Others

The report has provided a detailed breakup and analysis of the PEGylated proteins market based on the protein type. This includes colony stimulating factors, interferons, erythropoietin, mAbs, recombinant factor VII and others. According to the report, colony stimulating factors represented the largest segment.

Application Insights:

Cancer Treatment

Hepatitis

Chronic Kidney Diseases

Hemophilia

Multiple Sclerosis

Gastrointestinal Disorders

Others

A detailed breakup and analysis of the PEGylated proteins market based on the application has also been provided in the report. This includes cancer treatment, hepatitis, chronic kidney diseases, hemophilia, multiple sclerosis, gastrointestinal disorders, and others. According to the report, cancer treatment represented the largest segment.

End User Insights:

Pharmaceutical and Biotechnology Companies

Contract Research Organizations

Academic and Research Institutes

The report has provided a detailed breakup and analysis of the PEGylated proteins market based on the end user. This includes pharmaceutical and biotechnology companies, contract research organizations, and academic and research institutes. According to the report, pharmaceutical and biotechnology companies represented the largest segment.

Regional Insights:

North America

United States

Canada

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for PEGylated proteins. Some of the factors driving the North America PEGylated proteins market included the rising geriatric population, increasing prevalence of chronic diseases, and extensive research and development (R&D).

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global PEGylated proteins market. Detailed profiles of all major companies have also been provided. Some of the companies covered include Abcam plc, Biomatrik Inc., Creative PEGWorks, Iris Biotech GmbH, JenKem Technology USA Inc., Laysan Bio Inc., NOF America Corporation (NOF Corporation), Profacgen, Thermo Fisher Scientific Inc., etc.

Key Questions Answered in This Report

1. How big is the global PEGylated proteins market?
2. What is the expected growth rate of the global PEGylated proteins market during 2024-2032?
3. What are the key factors driving the global PEGylated proteins market?
4. What has been the impact of COVID-19 on the global PEGylated proteins market?
5. What is the breakup of the global PEGylated proteins market based on the product?
6. What is the breakup of the global PEGylated proteins market based on the protein type?
7. What is the breakup of the global PEGylated proteins market based on the application?
8. What is the breakup of the global PEGylated proteins market based on the end user?
9. What are the key regions in the global PEGylated proteins market?
10. Who are the key players/companies in the global PEGylated proteins market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global PEGylated Proteins Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product

6.1 Consumables
- 6.1.1 Market Trends
- 6.1.2 Key Segments
  - 6.1.2.1 PEGylation Reagents
  - 6.1.2.2 PEGylation Kits
- 6.1.3 Market Forecast
6.2 Services
- 6.2.1 Market Trends
- 6.2.2 Market Forecast

7 Market Breakup by Protein Type

7.1 Colony Stimulating Factors
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Interferons
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Erythropoietin
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 mAbs
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
7.5 Recombinant Factor VII
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast

8 Market Breakup by Application

8.1 Cancer Treatment
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Hepatitis
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Chronic Kidney Diseases
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
8.4 Hemophilia
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
8.5 Multiple Sclerosis
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
8.6 Gastrointestinal Disorders
- 8.6.1 Market Trends
- 8.6.2 Market Forecast
8.7 Others
- 8.7.1 Market Trends
- 8.7.2 Market Forecast

9 Market Breakup by End User

9.1 Pharmaceutical and Biotechnology Companies
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Contract Research Organizations
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Academic and Research Institutes
- 9.3.1 Market Trends
- 9.3.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia-Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

11.1 Overview
11.2 Drivers
11.3 Restraints
11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Abcam plc
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Biomatrik Inc.
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
- 15.3.3 Creative PEGWorks
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
- 15.3.4 Iris Biotech GmbH
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
- 15.3.5 JenKem Technology USA Inc.
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
- 15.3.6 Laysan Bio Inc.
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
- 15.3.7 NOF America Corporation (NOF Corporation)
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
- 15.3.8 Profacgen
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
- 15.3.9 Thermo Fisher Scientific Inc.
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: PEGylated Proteins Market: Major Drivers and Challenges
Figure 2: Global: PEGylated Proteins Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: PEGylated Proteins Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: PEGylated Proteins Market: Breakup by Product (in %), 2023
Figure 5: Global: PEGylated Proteins Market: Breakup by Protein Type (in %), 2023
Figure 6: Global: PEGylated Proteins Market: Breakup by Application (in %), 2023
Figure 7: Global: PEGylated Proteins Market: Breakup by End User (in %), 2023
Figure 8: Global: PEGylated Proteins Market: Breakup by Region (in %), 2023
Figure 9: Global: PEGylated Proteins (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: PEGylated Proteins (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: PEGylated Proteins (Services) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: PEGylated Proteins (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: PEGylated Proteins (Colony Stimulating Factors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: PEGylated Proteins (Colony Stimulating Factors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: PEGylated Proteins (Interferons) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: PEGylated Proteins (Interferons) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: PEGylated Proteins (Erythropoietin) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: PEGylated Proteins (Erythropoietin) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: PEGylated Proteins (mAbs) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: PEGylated Proteins (mAbs) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: PEGylated Proteins (Recombinant Factor VII) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: PEGylated Proteins (Recombinant Factor VII) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: PEGylated Proteins (Other Protein Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: PEGylated Proteins (Other Protein Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: PEGylated Proteins (Cancer Treatment) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: PEGylated Proteins (Cancer Treatment) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: PEGylated Proteins (Hepatitis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: PEGylated Proteins (Hepatitis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: PEGylated Proteins (Chronic Kidney Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: PEGylated Proteins (Chronic Kidney Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: PEGylated Proteins (Hemophilia) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: PEGylated Proteins (Hemophilia) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: PEGylated Proteins (Multiple Sclerosis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: PEGylated Proteins (Multiple Sclerosis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: PEGylated Proteins (Gastrointestinal Disorders) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: PEGylated Proteins (Gastrointestinal Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: Global: PEGylated Proteins (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: Global: PEGylated Proteins (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: Global: PEGylated Proteins (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: Global: PEGylated Proteins (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Global: PEGylated Proteins (Contract Research Organizations) Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Global: PEGylated Proteins (Contract Research Organizations) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Global: PEGylated Proteins (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Global: PEGylated Proteins (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: North America: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: North America: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: United States: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: United States: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: Canada: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: Canada: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: Asia-Pacific: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: Asia-Pacific: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: China: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: China: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Japan: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Japan: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: India: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: India: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: South Korea: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: South Korea: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Australia: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Australia: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: Indonesia: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: Indonesia: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: Others: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: Others: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Europe: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Europe: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Germany: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Germany: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: France: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: France: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: United Kingdom: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: United Kingdom: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Italy: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Italy: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Spain: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Spain: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Russia: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Russia: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Others: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Others: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Latin America: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Latin America: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 85: Brazil: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 86: Brazil: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 87: Mexico: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 88: Mexico: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 89: Others: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 90: Others: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 91: Middle East and Africa: PEGylated Proteins Market: Sales Value (in Million US$), 2018 & 2023
Figure 92: Middle East and Africa: PEGylated Proteins Market: Breakup by Country (in %), 2023
Figure 93: Middle East and Africa: PEGylated Proteins Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 94: Global: PEGylated Proteins Industry: Drivers, Restraints, and Opportunities
Figure 95: Global: PEGylated Proteins Industry: Value Chain Analysis
Figure 96: Global: PEGylated Proteins Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: PEGylated Proteins Market: Key Industry Highlights, 2023 & 2032
Table 2: Global: PEGylated Proteins Market Forecast: Breakup by Product (in Million US$), 2024-2032
Table 3: Global: PEGylated Proteins Market Forecast: Breakup by Protein Type (in Million US$), 2024-2032
Table 4: Global: PEGylated Proteins Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: PEGylated Proteins Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 6: Global: PEGylated Proteins Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: PEGylated Proteins Market: Competitive Structure
Table 8: Global: PEGylated Proteins Market: Key Players

02-2729-4219

+886-2-2729-4219